We have located links that may give you full text access.
COMPARATIVE STUDY
CONTROLLED CLINICAL TRIAL
JOURNAL ARTICLE
Clinical study of vitamin A combined with vitamin B in prevention and treatment of anemia in premature infants.
Minerva Pediatrica 2019 Februrary
BACKGROUND: We explored the clinical efficacy of vitamin A combined with vitamin B in the prevention and treatment of premature infants with anemia.
METHODS: One hundred fifty cases of premature infants were divided into three groups. Vitamin A combined with recombinant human erythropoietin (group A), vitamin B combined with recombinant human erythropoietin (group B), vitamin A combined with vitamin B combined with recombinant human erythropoietin treatment (recorded as group C). Levels of serum ferritin (SF), hemoglobin (Hb), hematocrit (Hct) and reticulocyte (Ret) in the serum of children before and after treatment were compared with those of three different treatments.
RESULTS: After treatment, the levels of SF, Hb and Ret in group C were higher than those in group A and B, and the level of Hct in group C was lower than that in group A and B (P<0.05) There was no significant difference in SF, Hb, Hct and Ret between the two groups (P>0.05). The ratio of blood transfusion in group C was lower than that in group A and B (P<0.05). There was no significant difference between the two groups (P>0.05).
CONCLUSIONS: Vitamin A combined with vitamin B can effectively prevent anemia in premature infants, which has important clinical significance.
METHODS: One hundred fifty cases of premature infants were divided into three groups. Vitamin A combined with recombinant human erythropoietin (group A), vitamin B combined with recombinant human erythropoietin (group B), vitamin A combined with vitamin B combined with recombinant human erythropoietin treatment (recorded as group C). Levels of serum ferritin (SF), hemoglobin (Hb), hematocrit (Hct) and reticulocyte (Ret) in the serum of children before and after treatment were compared with those of three different treatments.
RESULTS: After treatment, the levels of SF, Hb and Ret in group C were higher than those in group A and B, and the level of Hct in group C was lower than that in group A and B (P<0.05) There was no significant difference in SF, Hb, Hct and Ret between the two groups (P>0.05). The ratio of blood transfusion in group C was lower than that in group A and B (P<0.05). There was no significant difference between the two groups (P>0.05).
CONCLUSIONS: Vitamin A combined with vitamin B can effectively prevent anemia in premature infants, which has important clinical significance.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app